Edition:
United States

Anand Basu

Health Care REIT offers to buy HealthLease in $950 million deal

Aug 13 2014

Health Care REIT Inc said it would buy Canada's HealthLease Properties Real Estate Investment Trust in a deal valued at $950 million, including debt, to expand its presence in senior housing and post-acute care segments.

Hologic to buy Gen-Probe for $3.75 billion

Apr 30 2012

Medical device maker Hologic Inc is buying diagnostic test firm Gen-Probe Inc for $3.75 billion cash, gaining access to molecular diagnostics products used to screen for blood diseases and test transplant compatibility.

Spectrum says bladder cancer drug fails, buys Allos

Apr 05 2012

Spectrum Pharmaceuticals Inc said its experimental drug to treat a common form of bladder cancer failed to significantly reduce the recurrence of tumors in late-stage trials, sending its shares down 14 percent.

FDA approves Discovery Lab's lung drug, shares soar

Mar 06 2012

Discovery Laboratories Inc said U.S. health regulators have approved its drug to prevent a breathing disorder in premature infants, sending its shares up 35 percent in extended trade.

U.S. patent office rejects Amarin's patent application

Feb 29 2012

The U.S. patent office has rejected a patent application from Amarin Corp Plc for its key experimental heart drug.

UPDATE 1-US patent office rejects Amarin's patent application

Feb 29 2012

Feb 29 The U.S. patent office has rejected a patent application from Amarin Corp Plc for its key experimental heart drug.

Infinity stops cancer drug trial

Jan 27 2012

Infinity Pharmaceuticals pulled the plug on a mid-stage trial of its experimental pancreatic cancer drug as it failed to show benefit over a placebo, wiping off over 41 percent of its market value.

World News